$DNTH

$79.33 +$2.55 (3.32%) Close

$DNTH Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$DNTH Management Team

Mr. Marino Garcia

President

Chief Executive Officer

Director

Age 58

Compensation $8.843M USD

Sex Male

Mr. Ryan Savitz

Chief Financial Officer

Chief Business Officer Treasurer

Age 36

Compensation $4.002M USD

Sex Male

Mr. John King

Chief Commercial Officer

Age -

Compensation -

Sex Male

Mr. Adam Veness

Senior Vice President

General Counsel

Company Secretary

Age 39

Compensation -

Sex Male

Dr. Simrat Randhawa

Chief Medical Officer

Age 55

Compensation $4.035M USD

Sex Male

Ms. Alison Lawton

Independent Chairman of the Board

Age 63

Compensation $252.9K USD

Sex Female

Mr. Edward Carr

Chief Accounting Officer

Age 55

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Marino Garcia President Chief Executive Officer Director	58	$8.843M USD	Male
Mr. Ryan Savitz Chief Financial Officer Chief Business Officer Treasurer	36	$4.002M USD	Male
Mr. John King Chief Commercial Officer	-	-	Male
Mr. Adam Veness Senior Vice President General Counsel Company Secretary	39	-	Male
Dr. Simrat Randhawa Chief Medical Officer	55	$4.035M USD	Male
Ms. Alison Lawton Independent Chairman of the Board	63	$252.9K USD	Female
Mr. Edward Carr Chief Accounting Officer	55	-	Male

Board of Directors

From the proxy statement filed Apr 9, 2026

Directors

serving now

Independent

7 of 8

stated in the proxy

Average tenure

4.1 years

from year joined

CEO also chairs the board

Alison F. Lawton

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Sujay Kango	62	2025 1 year	Independent	Compensation Committee	None stated	$418,860
Anne McGeorge	65	2019 7 years	Independent	Audit Committee · Chair Nominating and Corporate Governance Committee	The Oncology Institute, Inc. (Nasdaq: TOI)	$232,382
Jonathan Violin, Ph.D.	50	2019 7 years	Independent	Science and Technology Committee	None stated	$217,476
Marino Garcia CEO	59	2021 5 years	Not independent	None stated	None stated	Paid as CEO
Paula Soteropoulos	58	2022 4 years	Independent	Audit Committee Compensation Committee · Chair	Rallybio Corporation (Nasdaq: RLYB)	$231,787
Alison F. Lawton Board chair	64	2020 6 years	Independent	Nominating and Corporate Governance Committee · Chair	ProQR Therapeutics N.V. (Nasdaq: PRQR)	$259,787
Simon Read, Ph.D.	55	2025 1 year	Independent	Nominating and Corporate Governance Committee Science and Technology Committee	None stated	$382,309
Steven Romano, M.D.	66	2024 2 years	Independent	Compensation Committee Science and Technology Committee · Chair	None stated	$225,647

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 9, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$DNTH Management Team

Mr. Marino Garcia

Mr. Ryan Savitz

Mr. John King

Mr. Adam Veness

Dr. Simrat Randhawa

Ms. Alison Lawton

Mr. Edward Carr

Board of Directors

Related-party transactions

No related-party transactions disclosed